Saroja Pharma Industries India Limited (NSE:SAROJA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceutical Business	701.29M	537.27M	406.69M	501.93M	556.33M
Pharmaceutical Business Growth	30.53%	32.11%	-18.97%	-9.78%	51.75%
Total	701.29M	537.27M	406.69M	501.93M	556.33M
Total Growth	30.53%	32.11%	-18.97%	-9.78%	51.75%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	491.69M	336.21M	450.03M	434.58M
India Growth	46.25%	-25.29%	3.56%	39.08%
Asia Pacific	45.58M	60.11M	46.63M	-
Asia Pacific Growth	-24.18%	28.92%	-	-
Europe	-	9.35M	459.00K	-
Europe Growth	-	1936.60%	-	-
Rest of The World	-	1.03M	-	-
Pakistan	-	-	-	91.55M
Pakistan Growth	-	-	-	102.66%
Jordan	-	-	-	9.97M
Jordan Growth	-	-	-	165.20%
Hong Kong	-	-	-	3.52M
Hong Kong Growth	-	-	-	-21.66%
Singapore	-	-	-	1.34M
Russia	-	-	-	4.08M
Egypt	-	-	-	7.76M
Ghana	-	-	-	459.00K
Ghana Growth	-	-	-	10.87%
Uruguay	-	-	-	818.00K
Uruguay Growth	-	-	-	265.18%
United Kingdom	-	-	-	1.06M
United Kingdom Growth	-	-	-	1076.67%
Netherland	-	-	-	1.19M
Total	537.27M	406.69M	497.12M	556.33M
Total Growth	32.11%	-18.19%	-10.64%	51.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 20, 2026

Data Sources Report a data error